Form 10-Q Minerva Neurosciences, For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Minerva Neurosciences (NERV) Misses Q3 EPS by 3c
November 3, 2016 8:42 AM EDTMinerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($0.24), $0.03 worse than the analyst estimate of ($0.21).
Cash, cash equivalents and marketable securities as of September 30, 2016 were approximately $91.9 million, compared to $32.2 million as of December 31, 2015. As previously stated, Minerva expects that its cash, cash equivalents and... More
